Detail akcie Arseus online

Business Summary: Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. The Company specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. It operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Fagron NV revenues increased 14% to EUR872M. Net income applicable to common stockholders increased 14% to EUR80.6M. Revenues reflect Fagron North America segment increase of 24% to EUR383M, Fagron Europe segment increase of 11% to EUR315.4M. Net income also reflects Derivatives - Hedging - Gain/Loss decrease of 40% to EUR2.2M (expense), Impairment of Receivables decrease of 34% to EUR1.1M (expense).